<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03992586</url>
  </required_header>
  <id_info>
    <org_study_id>RCG101</org_study_id>
    <nct_id>NCT03992586</nct_id>
  </id_info>
  <brief_title>Effect of Rose-colored Glass on Mood</brief_title>
  <official_title>Effect of Rose-colored Glass on Mood: A Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Florida Center for Dermatology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Florida Center for Dermatology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Decades of psychological research has highlighted the impact of visual perception on mood and
      happiness. The investigators hypothesized that literally seeing the world through rose
      colored glasses may have an effect on perception, mood, and happiness. After cataract
      surgery, which classically increases the vividness of perceived colors, patients report
      significant satisfaction. The investigators therefore sought to explore whether using pink
      colored lenses leads to a measurable impact on outcomes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized controlled clinical trial design will be performed. Subjects will be randomized
      for either pink lenses (treatment group) or clear lenses (placebo group).

      Subjects will be asked to wear the assigned glasses throughout the day during the course of
      the trial. Glasses will not be work while driving at night.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 30, 2018</start_date>
  <completion_date type="Actual">June 30, 2019</completion_date>
  <primary_completion_date type="Actual">June 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in Anxiety Scores on the Visual Analogue Scale at 1 week</measure>
    <time_frame>1 week</time_frame>
    <description>Scale range 0-100, higher values represent more anxiety</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Mood Scores on the Visual Analogue Scale</measure>
    <time_frame>1 week</time_frame>
    <description>Scale range 0-100, higher values represent more sadness</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Happiness Scores on the Visual Analogue Scale</measure>
    <time_frame>1 week</time_frame>
    <description>Scale range 0-100, higher values represent more happiness</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in the Center for Epidemiological Studies Depression Scale score</measure>
    <time_frame>1 week</time_frame>
    <description>Scale range 0-60, higher values suggest more depressive symptoms</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">38</enrollment>
  <condition>Mood</condition>
  <arm_group>
    <arm_group_label>Pink lenses</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pink-colored lenses</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Clear lenses</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Clear lenses</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Wearing pink glasses</intervention_name>
    <description>Wearing pink-colored lenses</description>
    <arm_group_label>Pink lenses</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Wearing clear glasses</intervention_name>
    <description>Wearing clear glasses</description>
    <arm_group_label>Clear lenses</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects over 18 years of age.

        Exclusion Criteria:

          -  Subjects who wear glasses on a regular basis.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jonathan Kantor, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Florida Center for Dermatology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>St Vincent's Medical Center</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>August 14, 2018</study_first_submitted>
  <study_first_submitted_qc>June 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 20, 2019</study_first_posted>
  <last_update_submitted>July 27, 2019</last_update_submitted>
  <last_update_submitted_qc>July 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 30, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Methamphetamine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

